Order Article Reprints

Krzystek-Korpacka M, Szczęśniak-Sięga B, Szczuka I, Fortuna P, Zawadzki M, Kubiak A, Mierzchała-Pasierb M, Fleszar MG, Lewandowski Ł, Serek P, et al. L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs. Cancers. 2020; 12(9):2594. https://doi.org/10.3390/cancers12092594

Krzystek-Korpacka, Małgorzata, Berenika Szczęśniak-Sięga, Izabela Szczuka, Paulina Fortuna, Marek Zawadzki, Agnieszka Kubiak, Magdalena Mierzchała-Pasierb, Mariusz G. Fleszar, Łukasz Lewandowski, Paweł Serek, and et al. 2020. "L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs" Cancers 12, no. 9: 2594. https://doi.org/10.3390/cancers12092594

Krzystek-Korpacka, M., Szczęśniak-Sięga, B., Szczuka, I., Fortuna, P., Zawadzki, M., Kubiak, A., Mierzchała-Pasierb, M., Fleszar, M. G., Lewandowski, Ł., Serek, P., Jamrozik, N., Neubauer, K., Wiśniewski, J., Kempiński, R., Witkiewicz, W., & Bednarz-Misa, I. (2020). L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs. Cancers, 12(9), 2594. https://doi.org/10.3390/cancers12092594